Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.
about
Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Budgetary impact of treating a ...... an Italian payer perspective.
@ast
Budgetary impact of treating a ...... an Italian payer perspective.
@en
type
label
Budgetary impact of treating a ...... an Italian payer perspective.
@ast
Budgetary impact of treating a ...... an Italian payer perspective.
@en
prefLabel
Budgetary impact of treating a ...... an Italian payer perspective.
@ast
Budgetary impact of treating a ...... an Italian payer perspective.
@en
P2093
P2860
P1433
P1476
Budgetary impact of treating a ...... an Italian payer perspective.
@en
P2093
Ashutosh Pathak
Gisoo Barnes
Monique Martin
Morgan Kruse
Rebecca Wildner
Udo Mueller
P2860
P304
P356
10.1371/JOURNAL.PONE.0134587
P407
P577
2015-08-12T00:00:00Z